R1 RCM Inc.

If you purchased R1 RCM Inc. securities and would like to join the action, please click "Join This Action" below.

We would handle the action on a contingent fee basis, whereby you would not be responsible for out of pocket payment of our legal fees or expenses.

RCM STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF R1 RCM INC. IS FAIR TO SHAREHOLDERS

 

August 1, 2024.

 

New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of R1 RCM Inc. (NASDAQ: RCM) to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 per share is fair to R1 shareholders.

 

The investigation concerns whether R1 and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for R1 shareholders; (2) determine whether TowerBrook and Clayton, Dubilier are underpaying for R1; and (3) disclose all material information necessary for R1 shareholders to adequately assess and value the merger consideration.

 

On behalf of R1 shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

 

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

 

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Signed pursuant to California Civil Code Section 1633.1, et seq., and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: September 11, 2024